The Pharmacy Times® Women's Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health conditions that affect women, including gynecological health and maternal health.
FDA Approves Pembrolizumab for Relapsed/Refractory PMBCL, Advanced Cervical Cancer
June 14th 2018Officials with the FDA have granted accelerated approval to pembrolizumab (Keytruda, Merck) for 2 new indications, including the treatment of refractory primary mediastinal large B-cell lymphoma (PMBCL), and recurrent metastatic cervical cancer in previously treated patients whose tumors express PD-L1.
Read More
CVS Health Announces Support of Women's Heart Health with $10 Million Commitment to Go Red For Women
February 1st 2017CVS Health has announced a major commitment in support of women's heart health, pledging to raise a minimum of $10 million over the next 3 years to support life-saving cardiovascular research and education.
Read More